Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Aged
Anti-Bacterial Agents
/ therapeutic use
Autoantibodies
Bone and Bones
/ diagnostic imaging
Female
Granuloma
/ diagnostic imaging
Humans
Immunocompetence
Interferon-gamma
/ immunology
Mycobacterium Infections, Nontuberculous
/ diagnostic imaging
Nontuberculous Mycobacteria
/ immunology
Positron-Emission Tomography
/ methods
Tomography, X-Ray Computed
/ methods
Virulence
Autoantibody
Disseminated infection
Interferon gamma
M. phlei
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
22 May 2019
22 May 2019
Historique:
received:
09
01
2019
accepted:
30
04
2019
entrez:
24
5
2019
pubmed:
24
5
2019
medline:
5
9
2019
Statut:
epublish
Résumé
Mycolicibacterium phlei (M. phlei) is known to be a non-pathogenic nontuberculous mycobacterium (NTM) which rarely causes diseases in humans. A disseminated NTM infection is mostly caused by the Mycobacterium avium complex (MAC) and is known to develop in immunocompromised hosts, like those with acquired immune deficiency syndrome (AIDS). Here, we report a case of disseminated M. phlei infection in an immunocompetent host carrying anti-interferon gamma (IFN-γ) autoantibodies. We detected M. phlei in multiple organs of an elderly woman with no significant medical history except positivity for anti-IFN-γ autoantibodies. She tested negative for human immunodeficiency virus (HIV)-1, 2/ Human T-cell leukemia virus type 1 (HTLV-1) antibody. High-resolution computed tomography (HRCT) of the chest demonstrated a nodule in the left S1 + 2 segment, interlobular septal thickening, multi lymphadenopathy, and osteolysis. A maximum intensity projection image following fluorodeoxyglucose-positron emission tomography (FDG-PET) revealed multifocal hypermetabolic lesions in the nodule and all the swollen lymph nodes seen in HRCT. FDG also accumulated in multiple bones. Advanced primary lung cancer was suspected, and biopsies of each lesion were performed. The pathology revealed caseating granuloma, positive for acid-fast bacteria, and DNA sequencing of the acid-fast bacteria confirmed the organism to be M. phlei. The patient also tested positive for anti-IFN-γ autoantibodies. Based on these findings, she was diagnosed with disseminated M. phlei infection, with anti-IFN-γ autoantibodies. Though known to be non-pathogenic, we show that M. phlei can be pathogenic like the MAC in immunocompetent individuals carrying anti-IFN-γ autoantibodies.
Sections du résumé
BACKGROUND
BACKGROUND
Mycolicibacterium phlei (M. phlei) is known to be a non-pathogenic nontuberculous mycobacterium (NTM) which rarely causes diseases in humans. A disseminated NTM infection is mostly caused by the Mycobacterium avium complex (MAC) and is known to develop in immunocompromised hosts, like those with acquired immune deficiency syndrome (AIDS). Here, we report a case of disseminated M. phlei infection in an immunocompetent host carrying anti-interferon gamma (IFN-γ) autoantibodies.
CASE PRESENTATION
METHODS
We detected M. phlei in multiple organs of an elderly woman with no significant medical history except positivity for anti-IFN-γ autoantibodies. She tested negative for human immunodeficiency virus (HIV)-1, 2/ Human T-cell leukemia virus type 1 (HTLV-1) antibody. High-resolution computed tomography (HRCT) of the chest demonstrated a nodule in the left S1 + 2 segment, interlobular septal thickening, multi lymphadenopathy, and osteolysis. A maximum intensity projection image following fluorodeoxyglucose-positron emission tomography (FDG-PET) revealed multifocal hypermetabolic lesions in the nodule and all the swollen lymph nodes seen in HRCT. FDG also accumulated in multiple bones. Advanced primary lung cancer was suspected, and biopsies of each lesion were performed. The pathology revealed caseating granuloma, positive for acid-fast bacteria, and DNA sequencing of the acid-fast bacteria confirmed the organism to be M. phlei. The patient also tested positive for anti-IFN-γ autoantibodies. Based on these findings, she was diagnosed with disseminated M. phlei infection, with anti-IFN-γ autoantibodies.
CONCLUSIONS
CONCLUSIONS
Though known to be non-pathogenic, we show that M. phlei can be pathogenic like the MAC in immunocompetent individuals carrying anti-IFN-γ autoantibodies.
Identifiants
pubmed: 31117976
doi: 10.1186/s12879-019-4050-z
pii: 10.1186/s12879-019-4050-z
pmc: PMC6530062
doi:
Substances chimiques
Anti-Bacterial Agents
0
Autoantibodies
0
Interferon-gamma
82115-62-6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
454Subventions
Organisme : Japan Agency for Medical Research and Development
ID : jp18fk0108043
Organisme : Japan Agency for Medical Research and Development
ID : jp18fk0108064
Organisme : Japan Agency for Medical Research and Development
ID : jp18fk0108075
Organisme : Japan Agency for Medical Research and Development
ID : jp18jm0510004
Organisme : Japan Society for the Promotion of Science
ID : jp18K08312
Organisme : Grants-in-Aid for Early-Career Scientists
ID : jp18K15966
Références
Microb Pathog. 2000 May;28(5):313-8
pubmed: 10799281
Med Clin North Am. 1959 Jan;43(1):273-90
pubmed: 13612432
Am J Respir Crit Care Med. 2008 Apr 1;177(7):793-7
pubmed: 18079497
Indian J Tuberc. 2008 Jan;55(1):28-33
pubmed: 18361308
Jpn J Infect Dis. 2011;64(4):265-71
pubmed: 21788699
Cardiol J. 2011;18(6):687-90
pubmed: 22113758
J Aerosol Med Pulm Drug Deliv. 2012 Apr;25(2):96-103
pubmed: 22149063
N Engl J Med. 2012 Aug 23;367(8):725-34
pubmed: 22913682
Mem Inst Oswaldo Cruz. 2013 Jun;108(4):457-62
pubmed: 23827995
J Infect Chemother. 2014 Jan;20(1):52-6
pubmed: 24462426
Semin Immunol. 2014 Dec;26(6):454-70
pubmed: 25453225
J Infect Chemother. 2015 Jun;21(6):468-72
pubmed: 25735882
J Rheumatol. 1989 Oct;16(10):1377-8
pubmed: 2810265
Foot Ankle Int. 1994 Dec;15(12):680-3
pubmed: 7894643
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 2):S1-25
pubmed: 9279284
Microbiology. 1998 Feb;144 ( Pt 2):577-87
pubmed: 9493394
Pediatr Nephrol. 1998 Jan;12(1):67-8
pubmed: 9502573